BioNTech (English Wikipedia)

Michael Barck (21 December 2023). "BioNTech: FDA erteilt Breakthrough-Therapy-Status für Krebsmittel BNT323". 4Investors (in German). Archived from the original on 14 December 2024. Retrieved 14 December 2024.

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227
U. Sahin; E. Derhovanessian; M. Miller; B. P. Kloke; P. Simon; M. Löwer; V. Bukur; A. D. Tadmor; U. Luxemburger; B. Schrörs; T. Omokoko; M. Vormehr; C. Albrecht; A. Paruzynski; A. N. Kuhn; J. Buck; S. Heesch; K. H. Schreeb; F. Müller; I. Ortseifer; I. Vogler; E. Godehardt; S. Attig; R. Rae; A. Breitkreuz; C. Tolliver; M. Suchan; G. Martic; A. Hohberger; P. Sorn; J. Diekmann; J. Ciesla; O. Waksmann; A. K. Brück; M. Witt; M. Zillgen; A. Rothermel; B. Kasemann; D. Langer; S. Bolte; M. Diken; S. Kreiter; R. Nemecek; C. Gebhardt; S. Grabbe; C. Höller; J. Utikal; C. Huber; C. Loquai; Ö. Türeci (2017). "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer". Nature. 547 (7662): 222–226. Bibcode:2017Natur.547..222S. doi:10.1038/nature23003. PMID 28678784.

aerzteblatt.de (Global: 3,794^th place; English: low place)

"Biontech sammelt Millionenbetrag ein". Deutsches Ärzteblatt. 10 July 2019. Retrieved 6 December 2019.
"Biontech und Pfizer: Ursprungspreis betrug 54 Euro pro Impfdosis". Deutsches Ärzteblatt (in German). 19 February 2021. Retrieved 8 April 2025.

allgemeine-zeitung.de (Global: low place; English: low place)

"Bebauung der GFZ-Kaserne: Mehr Platz für Biontech?". Allgemeine Zeitung Mainz. 25 May 2020. Retrieved 12 November 2020.

arstechnica.com (Global: 473^rd place; English: 338^th place)

Beth Mole (2 October 2023). "After being demoted and forced to retire, mRNA researcher wins Nobel". Ars Technica. Retrieved 3 October 2023.

biontech-imfs.de (Global: low place; English: low place)

"Eufets Becomes BioNTech Innovative Manufacturing Services", BioNTech IMFS, 18 September 2017, archived from the original on 8 June 2023, retrieved 11 November 2020

biontech.com (Global: low place; English: low place)

"Locations". BioNTech. Retrieved 6 May 2026.
"Our Board Members". BioNTech. Archived from the original on 13 December 2024. Retrieved 18 May 2026.

biontech.de (Global: low place; English: low place)

investors.biontech.de

"Prof. Christopher Huber". BioNTech. Archived from the original on 5 August 2021. Retrieved 5 August 2021.
"SEC Filing | BioNTech". investors.biontech.de. p. 130. Archived from the original on 16 January 2021. Retrieved 28 December 2020.
"BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". BioNTech. 4 September 2019. Archived from the original on 29 June 2023. Retrieved 27 December 2020.

biontech.de

"Aiming to address the global coronavirus pandemic: Project Lightspeed". BioNTech. 2020. Archived from the original on 18 December 2020. Retrieved 13 December 2020.
"Locations". BioNTech. Archived from the original on 3 January 2022. Retrieved 16 October 2022.

businessinsider.de (Global: 8,368^th place; English: low place)

"Knickt Biontech vor China ein? Taiwans Präsidentin erhebt Vorwürfe". Business Insider (in German). 1 June 2021. Retrieved 8 April 2025.

capital.de (Global: low place; English: low place)

Ben Stupples (2 March 2022). "Helmut Jeggle: vom Strüngmann-Vermögen zum eigenen Family Office". Capital. Archived from the original on 23 January 2025. Retrieved 15 December 2024.

cato.org (Global: 5,032^nd place; English: 3,198^th place)

Chris Edwards (24 September 2021). "The Triumph of Biotechnology and Private Capital". Cato Institute. Retrieved 15 December 2024.

clinicaltrialsarena.com (Global: low place; English: low place)

N, Vishnu Priya (26 August 2024). "BioNTech initiates global trials of mRNA-based lung cancer vaccine". Clinical Trials Arena. Archived from the original on 20 July 2025. Retrieved 20 July 2025.

cnbc.com (Global: 303^rd place; English: 191^st place)

Saheli Roy Choudhury (20 May 2021). "BioNTech to produce vaccines in Singapore, its new regional headquarters". CNBC. Archived from the original on 22 August 2021. Retrieved 14 December 2024.

deutsche-apotheker-zeitung.de (Global: low place; English: low place)

Thorsten Schüller (27 January 2023). "Biontech: Wegen Rahmenbedingungen ab nach England". Deutsche Apothekerzeitung. Retrieved 17 December 2023.
"Preise für mRNA-Impfstoffe steigen – Deutsche Apotheker Zeitung". www.deutsche-apotheker-zeitung.de (in German). Retrieved 8 April 2025.

doi.org (Global: 2^nd place; English: 2^nd place)

doi.org

Piotr Rzymski (7 December 2023). "The pivotal role of uridine modifications in the development of mRNA technology". Journal of Medical Sciences: e938. doi:10.20883/medical.e938. Archived from the original on 23 January 2025. Retrieved 15 December 2024.
Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227
"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.
"12 EU-Politik: Kommunale Abwasserrichtlinie". UmweltBriefe. 28 (12): 12. 2024. doi:10.5771/2941-0363-2024-12-12. ISSN 1866-0037.
U. Sahin; E. Derhovanessian; M. Miller; B. P. Kloke; P. Simon; M. Löwer; V. Bukur; A. D. Tadmor; U. Luxemburger; B. Schrörs; T. Omokoko; M. Vormehr; C. Albrecht; A. Paruzynski; A. N. Kuhn; J. Buck; S. Heesch; K. H. Schreeb; F. Müller; I. Ortseifer; I. Vogler; E. Godehardt; S. Attig; R. Rae; A. Breitkreuz; C. Tolliver; M. Suchan; G. Martic; A. Hohberger; P. Sorn; J. Diekmann; J. Ciesla; O. Waksmann; A. K. Brück; M. Witt; M. Zillgen; A. Rothermel; B. Kasemann; D. Langer; S. Bolte; M. Diken; S. Kreiter; R. Nemecek; C. Gebhardt; S. Grabbe; C. Höller; J. Utikal; C. Huber; C. Loquai; Ö. Türeci (2017). "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer". Nature. 547 (7662): 222–226. Bibcode:2017Natur.547..222S. doi:10.1038/nature23003. PMID 28678784.

dx.doi.org

"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.

dw.com (Global: 205^th place; English: 320^th place)

Fabian Schmidt (22 April 2020). "Germany to start coronavirus vaccine trials". Deutsche Welle. Archived from the original on 3 December 2024. Retrieved 15 December 2024.

eib.org (Global: 7,617^th place; English: 5,083^rd place)

"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Archived from the original on 1 May 2021. Retrieved 30 June 2021.
"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Archived from the original on 1 May 2021. Retrieved 3 February 2021.

europa.eu (Global: 62^nd place; English: 100^th place)

ec.europa.eu

"European Investment Bank provides funding of €50 million to BioNTech as part of the Investment Plan for Europe". European Commission. 17 December 2019. Archived from the original on 4 May 2023. Retrieved 21 November 2020.
"Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing". European Commission. 11 June 2020. Archived from the original on 4 September 2023. Retrieved 21 November 2020.

faz.net (Global: 282^nd place; English: 1,243^rd place)

"Biontech: An der Börse über 100 Milliarden Dollar wert". Frankfurter Allgemeine Zeitung (in German). 5 August 2021. Archived from the original on 2 September 2024. Retrieved 2 September 2024.
Sebastian Balzter (27 January 2023). "Biontech auf Britisch". Frankfurter Allgemeine Zeitung (in German). Retrieved 14 December 2024.
Thorsten Winter (6 November 2018). "Krebs und Infektionen: Neuartige Impfstoffe als Ziel". Frankfurter Allgemeine Zeitung. Archived from the original on 3 December 2024. Retrieved 14 December 2024.

fda.gov (Global: 470^th place; English: 329^th place)

Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions, archived from the original on 17 December 2020, retrieved 22 December 2020

fiercebiotech.com (Global: low place; English: 6,413^th place)

Nick Paul Taylor (21 September 2016). "Genentech lays $310M wager on BioNTech's mRNA cancer vaccine platform". FierceBiotech. Archived from the original on 20 July 2023. Retrieved 7 December 2020.
Nick Paul Taylor (9 July 2019). "BioNTech raises $325M series B round to advance cancer pipeline". Fierce Biotech. Archived from the original on 28 December 2022. Retrieved 28 December 2022.

finance.yahoo.com (Global: 894^th place; English: 567^th place)

"BioNTech Completes Acquisition of InstaDeep". Yahoo Finance (Press release). 31 July 2023. Archived from the original on 1 August 2023. Retrieved 1 August 2023.

forbes.hu (Global: low place; English: low place)

"Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához". forbes.hu (in Hungarian). 9 November 2020. Archived from the original on 26 January 2021. Retrieved 22 December 2020.

france24.com (Global: 344^th place; English: 362^nd place)

"BioNTech's founders: scientist couple in global spotlight". France 24. 13 November 2020. Archived from the original on 14 February 2021. Retrieved 22 December 2020.

ft.com (Global: 193^rd place; English: 127^th place)

Joe Miller, Clive Cookson (16 December 2020). "FT People of the Year: BioNTech's Ugur Sahin and Ozlem Tureci". Financial Times. Archived from the original on 16 December 2020. Retrieved 26 August 2024.

gcs-web.com (Global: 7,581^st place; English: 4,912^th place)

biontechse.gcs-web.com

Sylke Maas; John Woolford; Jasmina Alatovic (16 August 2018). "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". BioNTech. Archived from the original on 24 November 2020. Retrieved 28 December 2022.

genomeweb.com (Global: low place; English: low place)

"TheraCode to Acquire JPT Peptide Technologies". GenomeWeb. 11 May 2009. Archived from the original on 2 January 2023. Retrieved 7 December 2020.

globenewswire.com (Global: 2,858^th place; English: 1,554^th place)

"BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". GlobeNewswire News Room. 15 September 2020. Archived from the original on 25 August 2023. Retrieved 3 February 2021.

goethe-university-frankfurt.de (Global: low place; English: low place)

"Prize Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize 2022". Goethe University Frankfurt. 2022. Archived from the original on 3 December 2023. Retrieved 15 December 2024.

gov.uk (Global: 401^st place; English: 228^th place)

"UK medicines regulator gives approval for first UK COVID-19 vaccine". Government of the United Kingdom. 2 December 2020. Archived from the original on 17 March 2021. Retrieved 2 December 2020.

marketwatch.com (Global: 1,878^th place; English: 1,099^th place)

Callum Keown, Lina Saigol (8 December 2020). "Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer". MarketWatch. Archived from the original on 29 December 2022. Retrieved 29 December 2022.

merkurist.de (Global: low place; English: low place)

Kroh, Peter (19 February 2021). "Abzock-Vorwurf gegen Biontech und Pfizer". merkurist.de (in German). Retrieved 8 April 2025.

nasdaq.com (Global: 3,313^th place; English: 2,339^th place)

"BioNTech SE", NASDAQ, archived from the original on 11 May 2021, retrieved 12 November 2020

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227
U. Sahin; E. Derhovanessian; M. Miller; B. P. Kloke; P. Simon; M. Löwer; V. Bukur; A. D. Tadmor; U. Luxemburger; B. Schrörs; T. Omokoko; M. Vormehr; C. Albrecht; A. Paruzynski; A. N. Kuhn; J. Buck; S. Heesch; K. H. Schreeb; F. Müller; I. Ortseifer; I. Vogler; E. Godehardt; S. Attig; R. Rae; A. Breitkreuz; C. Tolliver; M. Suchan; G. Martic; A. Hohberger; P. Sorn; J. Diekmann; J. Ciesla; O. Waksmann; A. K. Brück; M. Witt; M. Zillgen; A. Rothermel; B. Kasemann; D. Langer; S. Bolte; M. Diken; S. Kreiter; R. Nemecek; C. Gebhardt; S. Grabbe; C. Höller; J. Utikal; C. Huber; C. Loquai; Ö. Türeci (2017). "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer". Nature. 547 (7662): 222–226. Bibcode:2017Natur.547..222S. doi:10.1038/nature23003. PMID 28678784.

nytimes.com (Global: 7^th place; English: 7^th place)

"Covid-19: Studies Indicate Pfizer-BioNTech Vaccine Protects Against the Most Severe Outcomes of Some Virus Variants". The New York Times. 5 May 2021. Retrieved 14 December 2024.

nzz.ch (Global: 710^th place; English: 2,248^th place)

Sander, Matthias (2 June 2021). "Corona-Impfstoff: Helfen Private Taiwan nach Problemen mit China?". Neue Zürcher Zeitung (in Swiss High German). ISSN 0376-6829. Retrieved 8 April 2025.

pharma-food.de (Global: low place; English: low place)

Ansgar Kretschmer (27 October 2021). "Biontech plant Impfstoff-Produktionsanlage in Afrika". Pharma + Food (in German). Archived from the original on 14 December 2024. Retrieved 14 December 2024.
Nora Menzel (14 November 2022). "Biontech übernimmt GMP-Produktionsanlage in Singapur". Pharma + Food (in German). Retrieved 14 December 2024.

pharmavoice.com (Global: low place; English: low place)

Amy Baxter (14 August 2024). "Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope". PharmaVoice. Archived from the original on 2 December 2024. Retrieved 15 December 2024.

pharmazeutische-zeitung.de (Global: low place; English: low place)

Christina Hohmann-Jeddi (22 June 2021). "mRNA-Vakzine: Biontech startet Phase-II-Studie mit Krebsimpfstoff". Pharmazeutische Zeitung (in German). Archived from the original on 10 July 2024. Retrieved 14 December 2024.

politico.eu (Global: 941^st place; English: 653^rd place)

"Commission approves BioNTech/Pfizer vaccine". Politico. 21 December 2020. Archived from the original on 5 May 2021. Retrieved 22 December 2020.

publishing.service.gov.uk (Global: 1,837^th place; English: 948^th place)

assets.publishing.service.gov.uk

"Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine" (PDF). Government of the United Kingdom. 2 December 2020. Archived (PDF) from the original on 3 December 2020. Retrieved 2 December 2020.

reuters.com (Global: 38^th place; English: 30^th place)

Rebecca Spalding, Joshua Franklin (9 October 2019). "Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility". Reuters. Archived from the original on 15 January 2021. Retrieved 7 December 2020.
Ludwig Burger (15 March 2020). "BioNTech in China alliance with Fosun over coronavirus vaccine candidate". Reuters. Archived from the original on 14 November 2020. Retrieved 22 July 2021.
Ludwig Burger (29 June 2020). "Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech". Reuters. Frankfurt. Archived from the original on 14 November 2020. Retrieved 2 August 2020.
Ludwig Burger; Pratik Jain; Leroy Leo (10 January 2023). "Germany's BioNTech buys British AI startup InstaDeep". Reuters.
Burger, Ludwig (12 June 2025). "BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals". Reuters. Retrieved 15 June 2025.
"BioNTech buys German site from Novartis to boost vaccine output". Reuters. 17 September 2020. Retrieved 14 December 2024.

rnd.de (Global: 3,569^th place; English: low place)

"Moderna will seine erste Fabrik für Herstellung von mRNA-Impfstoffen in Afrika bauen". RedaktionsNetzwerk Deutschland. 8 March 2022. Retrieved 26 March 2022.

sec.gov (Global: 617^th place; English: 437^th place)

"BioNTech 2025 Annual Report (Form 20-F)". U.S. Securities and Exchange Commission. 10 March 2026. Retrieved 26 March 2026.

sec.report (Global: low place; English: low place)

BioNTech SE (9 September 2019), "Form F-1", U.S. Securities and Exchange Commission, archived from the original on 14 February 2021, retrieved 23 September 2020

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227

smh.com.au (Global: 154^th place; English: 94^th place)

Liam Mannix (7 October 2022). "mRNA giant wants changes to vaccine regulations to speed up new jabs". The Sydney Morning Herald (in German). Retrieved 14 December 2024.

spiegel.de (Global: 87^th place; English: 363^rd place)

Thomas Schulz (4 February 2024). "Wie Biontech zum zweiten Mal Medizingeschichte schreiben will". Der Spiegel. Archived from the original on 15 September 2024. Retrieved 14 December 2024.
"Biontech schließt Standorte in Deutschland: 1860 Stellen in Gefahr". Der Spiegel (in German). 5 May 2026. ISSN 2195-1349. Retrieved 6 May 2026.
"Biontech kauft Krebsspezialisten in den USA". Der Spiegel (in German). Retrieved 19 July 2021.

sueddeutsche.de (Global: 267^th place; English: 1,211^th place)

Mascolo, Georg (18 February 2021). "Corona-Impfstoff: Biontech wollte 54,08 Euro für eine Dosis". Süddeutsche.de (in German). Retrieved 8 April 2025.

swr.de (Global: 1,940^th place; English: 4,991^st place)

"BioNTech sichert sich Mega-Deal: Bis zu 11 Milliarden Dollar für neue Krebstherapien". SWR Aktuell (in German). 3 June 2025. Retrieved 6 May 2026.
"Biontech produziert Impfstoffe in RLP-Partnerland Ruanda". Südwestrundfunk (in German). 18 December 2023. Retrieved 14 December 2024.

tagesschau.de (Global: 772^nd place; English: 2,796^th place)

"BioNTech will 2026 Krebsmedikament auf Markt bringen". Tagesschau (in German). 20 March 2020. Retrieved 26 November 2023.

technical.ly (Global: low place; English: low place)

Huffman, Sarah (9 January 2026). "Penn, BioNTech launch $50M fund to support early-stage life sciences startups". Technical.ly. Archived from the original on 18 January 2026. Retrieved 26 January 2026.

theguardian.com (Global: 16^th place; English: 11^th place)

Hannah Devlin, Julia Kollewe (26 November 2021). "BioNTech says it could tweak Covid vaccine in 100 days if needed". The Guardian. Archived from the original on 27 November 2021. Retrieved 14 December 2024.

triastek.com (Global: low place; English: low place)

治汇网络科技(上海)有限公司-高端网站建设. "Triastek announces research collaboration and platform technology license agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics-News-三迭纪 TRIASTEK". www.triastek.com (in Korean). Archived from the original on 15 January 2025. Retrieved 29 June 2025.

ump.edu.pl (Global: low place; English: low place)

jmsnew.ump.edu.pl

Piotr Rzymski (7 December 2023). "The pivotal role of uridine modifications in the development of mRNA technology". Journal of Medical Sciences: e938. doi:10.20883/medical.e938. Archived from the original on 23 January 2025. Retrieved 15 December 2024.

web.archive.org (Global: 1^st place; English: 1^st place)

"BioNTech CEO on vaccine progress with Pfizer – YouTube". 10 November 2020. Archived from the original on 2 January 2023. Retrieved 14 June 2021 – via YouTube.
BioNTech SE (9 September 2019), "Form F-1", U.S. Securities and Exchange Commission, archived from the original on 14 February 2021, retrieved 23 September 2020
Amy Baxter (14 August 2024). "Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope". PharmaVoice. Archived from the original on 2 December 2024. Retrieved 15 December 2024.
Hannah Devlin, Julia Kollewe (26 November 2021). "BioNTech says it could tweak Covid vaccine in 100 days if needed". The Guardian. Archived from the original on 27 November 2021. Retrieved 14 December 2024.
"BioNTech's founders: scientist couple in global spotlight". France 24. 13 November 2020. Archived from the original on 14 February 2021. Retrieved 22 December 2020.
"Prof. Christopher Huber". BioNTech. Archived from the original on 5 August 2021. Retrieved 5 August 2021.
"SEC Filing | BioNTech". investors.biontech.de. p. 130. Archived from the original on 16 January 2021. Retrieved 28 December 2020.
Joe Miller, Clive Cookson (16 December 2020). "FT People of the Year: BioNTech's Ugur Sahin and Ozlem Tureci". Financial Times. Archived from the original on 16 December 2020. Retrieved 26 August 2024.
Ben Stupples (2 March 2022). "Helmut Jeggle: vom Strüngmann-Vermögen zum eigenen Family Office". Capital. Archived from the original on 23 January 2025. Retrieved 15 December 2024.
"Eufets Becomes BioNTech Innovative Manufacturing Services", BioNTech IMFS, 18 September 2017, archived from the original on 8 June 2023, retrieved 11 November 2020
"TheraCode to Acquire JPT Peptide Technologies". GenomeWeb. 11 May 2009. Archived from the original on 2 January 2023. Retrieved 7 December 2020.
"Prize Winners of the Paul Ehrlich and Ludwig Darmstaedter Prize 2022". Goethe University Frankfurt. 2022. Archived from the original on 3 December 2023. Retrieved 15 December 2024.
"Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához". forbes.hu (in Hungarian). 9 November 2020. Archived from the original on 26 January 2021. Retrieved 22 December 2020.
Piotr Rzymski (7 December 2023). "The pivotal role of uridine modifications in the development of mRNA technology". Journal of Medical Sciences: e938. doi:10.20883/medical.e938. Archived from the original on 23 January 2025. Retrieved 15 December 2024.
Nick Paul Taylor (21 September 2016). "Genentech lays $310M wager on BioNTech's mRNA cancer vaccine platform". FierceBiotech. Archived from the original on 20 July 2023. Retrieved 7 December 2020.
Sylke Maas; John Woolford; Jasmina Alatovic (16 August 2018). "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". BioNTech. Archived from the original on 24 November 2020. Retrieved 28 December 2022.
Nick Paul Taylor (9 July 2019). "BioNTech raises $325M series B round to advance cancer pipeline". Fierce Biotech. Archived from the original on 28 December 2022. Retrieved 28 December 2022.
Callum Keown, Lina Saigol (8 December 2020). "Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer". MarketWatch. Archived from the original on 29 December 2022. Retrieved 29 December 2022.
"BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". BioNTech. 4 September 2019. Archived from the original on 29 June 2023. Retrieved 27 December 2020.
"European Investment Bank provides funding of €50 million to BioNTech as part of the Investment Plan for Europe". European Commission. 17 December 2019. Archived from the original on 4 May 2023. Retrieved 21 November 2020.
"BioNTech SE", NASDAQ, archived from the original on 11 May 2021, retrieved 12 November 2020
Rebecca Spalding, Joshua Franklin (9 October 2019). "Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility". Reuters. Archived from the original on 15 January 2021. Retrieved 7 December 2020.
"Aiming to address the global coronavirus pandemic: Project Lightspeed". BioNTech. 2020. Archived from the original on 18 December 2020. Retrieved 13 December 2020.
Ludwig Burger (15 March 2020). "BioNTech in China alliance with Fosun over coronavirus vaccine candidate". Reuters. Archived from the original on 14 November 2020. Retrieved 22 July 2021.
Fabian Schmidt (22 April 2020). "Germany to start coronavirus vaccine trials". Deutsche Welle. Archived from the original on 3 December 2024. Retrieved 15 December 2024.
"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Archived from the original on 1 May 2021. Retrieved 30 June 2021.
"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Archived from the original on 1 May 2021. Retrieved 3 February 2021.
"Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing". European Commission. 11 June 2020. Archived from the original on 4 September 2023. Retrieved 21 November 2020.
"BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". GlobeNewswire News Room. 15 September 2020. Archived from the original on 25 August 2023. Retrieved 3 February 2021.
Ludwig Burger (29 June 2020). "Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech". Reuters. Frankfurt. Archived from the original on 14 November 2020. Retrieved 2 August 2020.
"Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine" (PDF). Government of the United Kingdom. 2 December 2020. Archived (PDF) from the original on 3 December 2020. Retrieved 2 December 2020.
"UK medicines regulator gives approval for first UK COVID-19 vaccine". Government of the United Kingdom. 2 December 2020. Archived from the original on 17 March 2021. Retrieved 2 December 2020.
Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions, archived from the original on 17 December 2020, retrieved 22 December 2020
"Commission approves BioNTech/Pfizer vaccine". Politico. 21 December 2020. Archived from the original on 5 May 2021. Retrieved 22 December 2020.
"Biontech: An der Börse über 100 Milliarden Dollar wert". Frankfurter Allgemeine Zeitung (in German). 5 August 2021. Archived from the original on 2 September 2024. Retrieved 2 September 2024.
Thomas Schulz (4 February 2024). "Wie Biontech zum zweiten Mal Medizingeschichte schreiben will". Der Spiegel. Archived from the original on 15 September 2024. Retrieved 14 December 2024.
Christina Hohmann-Jeddi (22 June 2021). "mRNA-Vakzine: Biontech startet Phase-II-Studie mit Krebsimpfstoff". Pharmazeutische Zeitung (in German). Archived from the original on 10 July 2024. Retrieved 14 December 2024.
Jürgen Salz (12 April 2024). "Biontech: "Das würde ein neues Zeitalter in der Krebstherapie einleiten"". Wirtschaftswoche. Archived from the original on 31 May 2024. Retrieved 14 December 2024.
Michael Barck (21 December 2023). "BioNTech: FDA erteilt Breakthrough-Therapy-Status für Krebsmittel BNT323". 4Investors (in German). Archived from the original on 14 December 2024. Retrieved 14 December 2024.
"BioNTech Completes Acquisition of InstaDeep". Yahoo Finance (Press release). 31 July 2023. Archived from the original on 1 August 2023. Retrieved 1 August 2023.
治汇网络科技(上海)有限公司-高端网站建设. "Triastek announces research collaboration and platform technology license agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics-News-三迭纪 TRIASTEK". www.triastek.com (in Korean). Archived from the original on 15 January 2025. Retrieved 29 June 2025.
Huffman, Sarah (9 January 2026). "Penn, BioNTech launch $50M fund to support early-stage life sciences startups". Technical.ly. Archived from the original on 18 January 2026. Retrieved 26 January 2026.
"Locations". BioNTech. Archived from the original on 3 January 2022. Retrieved 16 October 2022.
Ansgar Kretschmer (27 October 2021). "Biontech plant Impfstoff-Produktionsanlage in Afrika". Pharma + Food (in German). Archived from the original on 14 December 2024. Retrieved 14 December 2024.
Saheli Roy Choudhury (20 May 2021). "BioNTech to produce vaccines in Singapore, its new regional headquarters". CNBC. Archived from the original on 22 August 2021. Retrieved 14 December 2024.
"Our Board Members". BioNTech. Archived from the original on 13 December 2024. Retrieved 18 May 2026.
N, Vishnu Priya (26 August 2024). "BioNTech initiates global trials of mRNA-based lung cancer vaccine". Clinical Trials Arena. Archived from the original on 20 July 2025. Retrieved 20 July 2025.
Thorsten Winter (6 November 2018). "Krebs und Infektionen: Neuartige Impfstoffe als Ziel". Frankfurter Allgemeine Zeitung. Archived from the original on 3 December 2024. Retrieved 14 December 2024.

welt.de (Global: 255^th place; English: 947^th place)

"Özlem Türeci und Uğur Şahin: Biontech-Gründer verlassen Unternehmen und gründen neue Firma". Die Welt (in German). 10 March 2026. Retrieved 10 March 2026.

wiwo.de (Global: 4,050^th place; English: 9,700^th place)

Jürgen Salz (12 April 2024). "Biontech: "Das würde ein neues Zeitalter in der Krebstherapie einleiten"". Wirtschaftswoche. Archived from the original on 31 May 2024. Retrieved 14 December 2024.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Lena M. Kranz; Mustafa Diken; Heinrich Haas; Sebastian Kreiter; Carmen Loquai (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, 534 (7607): 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227
"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.
"12 EU-Politik: Kommunale Abwasserrichtlinie". UmweltBriefe. 28 (12): 12. 2024. doi:10.5771/2941-0363-2024-12-12. ISSN 1866-0037.
"Biontech schließt Standorte in Deutschland: 1860 Stellen in Gefahr". Der Spiegel (in German). 5 May 2026. ISSN 2195-1349. Retrieved 6 May 2026.
Sander, Matthias (2 June 2021). "Corona-Impfstoff: Helfen Private Taiwan nach Problemen mit China?". Neue Zürcher Zeitung (in Swiss High German). ISSN 0376-6829. Retrieved 8 April 2025.

youtube.com (Global: 13^th place; English: 14^th place)

"BioNTech CEO on vaccine progress with Pfizer – YouTube". 10 November 2020. Archived from the original on 2 January 2023. Retrieved 14 June 2021 – via YouTube.

zdf.de (Global: 1,615^th place; English: 5,878^th place)

"Krebs-Impfstoffe: Biontech plant Therapieansatz vor 2030". ZDFheute (in German). Retrieved 26 November 2023.

BioNTech (English Wikipedia)

4investors.de (Global: low place; English: low place)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

aerzteblatt.de (Global: 3,794th place; English: low place)

allgemeine-zeitung.de (Global: low place; English: low place)

arstechnica.com (Global: 473rd place; English: 338th place)

biontech-imfs.de (Global: low place; English: low place)

biontech.com (Global: low place; English: low place)

biontech.de (Global: low place; English: low place)

investors.biontech.de

biontech.de

businessinsider.de (Global: 8,368th place; English: low place)

capital.de (Global: low place; English: low place)

cato.org (Global: 5,032nd place; English: 3,198th place)

clinicaltrialsarena.com (Global: low place; English: low place)

cnbc.com (Global: 303rd place; English: 191st place)

deutsche-apotheker-zeitung.de (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

doi.org

dx.doi.org

dw.com (Global: 205th place; English: 320th place)

eib.org (Global: 7,617th place; English: 5,083rd place)

europa.eu (Global: 62nd place; English: 100th place)

ec.europa.eu

faz.net (Global: 282nd place; English: 1,243rd place)

fda.gov (Global: 470th place; English: 329th place)

fiercebiotech.com (Global: low place; English: 6,413th place)

finance.yahoo.com (Global: 894th place; English: 567th place)

forbes.hu (Global: low place; English: low place)

france24.com (Global: 344th place; English: 362nd place)

ft.com (Global: 193rd place; English: 127th place)

gcs-web.com (Global: 7,581st place; English: 4,912th place)

biontechse.gcs-web.com

genomeweb.com (Global: low place; English: low place)

globenewswire.com (Global: 2,858th place; English: 1,554th place)

goethe-university-frankfurt.de (Global: low place; English: low place)

gov.uk (Global: 401st place; English: 228th place)

marketwatch.com (Global: 1,878th place; English: 1,099th place)

merkurist.de (Global: low place; English: low place)

nasdaq.com (Global: 3,313th place; English: 2,339th place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

nytimes.com (Global: 7th place; English: 7th place)

nzz.ch (Global: 710th place; English: 2,248th place)

pharma-food.de (Global: low place; English: low place)

pharmavoice.com (Global: low place; English: low place)

pharmazeutische-zeitung.de (Global: low place; English: low place)

politico.eu (Global: 941st place; English: 653rd place)

publishing.service.gov.uk (Global: 1,837th place; English: 948th place)

assets.publishing.service.gov.uk

reuters.com (Global: 38th place; English: 30th place)

rnd.de (Global: 3,569th place; English: low place)

sec.gov (Global: 617th place; English: 437th place)

sec.report (Global: low place; English: low place)

semanticscholar.org (Global: 15th place; English: 8th place)

api.semanticscholar.org

smh.com.au (Global: 154th place; English: 94th place)

spiegel.de (Global: 87th place; English: 363rd place)

sueddeutsche.de (Global: 267th place; English: 1,211th place)

swr.de (Global: 1,940th place; English: 4,991st place)

tagesschau.de (Global: 772nd place; English: 2,796th place)

technical.ly (Global: low place; English: low place)

theguardian.com (Global: 16th place; English: 11th place)

triastek.com (Global: low place; English: low place)

ump.edu.pl (Global: low place; English: low place)

jmsnew.ump.edu.pl

web.archive.org (Global: 1st place; English: 1st place)

welt.de (Global: 255th place; English: 947th place)

wiwo.de (Global: 4,050th place; English: 9,700th place)

worldcat.org (Global: 4th place; English: 4th place)

search.worldcat.org

youtube.com (Global: 13th place; English: 14th place)

zdf.de (Global: 1,615th place; English: 5,878th place)

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

aerzteblatt.de (Global: 3,794^th place; English: low place)

arstechnica.com (Global: 473^rd place; English: 338^th place)

businessinsider.de (Global: 8,368^th place; English: low place)

cato.org (Global: 5,032^nd place; English: 3,198^th place)

cnbc.com (Global: 303^rd place; English: 191^st place)

doi.org (Global: 2^nd place; English: 2^nd place)

dw.com (Global: 205^th place; English: 320^th place)

eib.org (Global: 7,617^th place; English: 5,083^rd place)

europa.eu (Global: 62^nd place; English: 100^th place)

faz.net (Global: 282^nd place; English: 1,243^rd place)

fda.gov (Global: 470^th place; English: 329^th place)

fiercebiotech.com (Global: low place; English: 6,413^th place)

finance.yahoo.com (Global: 894^th place; English: 567^th place)

france24.com (Global: 344^th place; English: 362^nd place)

ft.com (Global: 193^rd place; English: 127^th place)

gcs-web.com (Global: 7,581^st place; English: 4,912^th place)

globenewswire.com (Global: 2,858^th place; English: 1,554^th place)

gov.uk (Global: 401^st place; English: 228^th place)

marketwatch.com (Global: 1,878^th place; English: 1,099^th place)

nasdaq.com (Global: 3,313^th place; English: 2,339^th place)

nih.gov (Global: 5^th place; English: 5^th place)

nytimes.com (Global: 7^th place; English: 7^th place)

nzz.ch (Global: 710^th place; English: 2,248^th place)

politico.eu (Global: 941^st place; English: 653^rd place)

publishing.service.gov.uk (Global: 1,837^th place; English: 948^th place)

reuters.com (Global: 38^th place; English: 30^th place)

rnd.de (Global: 3,569^th place; English: low place)

sec.gov (Global: 617^th place; English: 437^th place)

semanticscholar.org (Global: 15^th place; English: 8^th place)

smh.com.au (Global: 154^th place; English: 94^th place)

spiegel.de (Global: 87^th place; English: 363^rd place)

sueddeutsche.de (Global: 267^th place; English: 1,211^th place)

swr.de (Global: 1,940^th place; English: 4,991^st place)

tagesschau.de (Global: 772^nd place; English: 2,796^th place)

theguardian.com (Global: 16^th place; English: 11^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

welt.de (Global: 255^th place; English: 947^th place)

wiwo.de (Global: 4,050^th place; English: 9,700^th place)

worldcat.org (Global: 4^th place; English: 4^th place)

youtube.com (Global: 13^th place; English: 14^th place)

zdf.de (Global: 1,615^th place; English: 5,878^th place)